{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:56:08Z","timestamp":1766400968780,"version":"3.48.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019886","name":"Legend Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/13696998.2025.2583668","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:18:04Z","timestamp":1762168684000},"page":"1989-1998","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Healthcare resource utilization and costs in patients with multiple myeloma who received 1 to 3 prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug, and were exposed to and discontinued lenalidomide in the United States"],"prefix":"10.1080","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2934-6518","authenticated-orcid":false,"given":"Sundar","family":"Jagannath","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai","place":["New York, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-9466","authenticated-orcid":false,"given":"Akshay","family":"Kharat","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC","place":["Horsham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-0012","authenticated-orcid":false,"given":"Eric","family":"Chinaeke","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC","place":["Horsham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4020-6519","authenticated-orcid":false,"given":"Alex Z.","family":"Fu","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC","place":["Horsham, USA"]},{"name":"Georgetown University Medical Center","place":["Washington, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-9906","authenticated-orcid":false,"given":"Matthew","family":"Perciavalle","sequence":"additional","affiliation":[{"name":"Legend Biotech USA Inc","place":["Somerset, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5477-9756","authenticated-orcid":false,"given":"Stephen","family":"Huo","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC","place":["Raritan, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9605-3980","authenticated-orcid":false,"given":"Zaina P.","family":"Qureshi","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC","place":["Horsham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9010003"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102885"},{"key":"e_1_3_4_4_1","volume-title":"Cancer Facts & Figures 2023","author":"American Cancer Society","year":"2023","unstructured":"American Cancer Society. Cancer Facts & Figures 2023. Atlanta (GA): American Cancer Society; 2023."},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.612696"},{"key":"e_1_3_4_6_1","volume-title":"StatPearls","author":"Ahmed A","year":"2025","unstructured":"Ahmed A, Killeen RB. Relapsed and refractory multiple myeloma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30020179"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00359-2"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010155"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000109"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000528"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000829668.16924.bb"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.138"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14213"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07503-y"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-022-00198-0"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-1003"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-021-00175-z"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.380"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.29.8.917"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0113"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1648802"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1361035"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16357"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0104"},{"key":"e_1_3_4_26_1","unstructured":"Consumer Price Index for All Urban Consumers (CPI-U). [Internet]. Washington (DC): U.S. Bureau Of Labor Statistics. Available from: https:\/\/data.bls.gov\/cgi-bin\/surveymost?cu."},{"key":"e_1_3_4_27_1","volume-title":"Commercial claims and encounters: medicare supplemental","author":"Truven Health Analytics","year":"2016","unstructured":"Truven Health Analytics. Commercial claims and encounters: medicare supplemental. Ann Arbor (MI): Truven Health Marketscan Research Databases; 2016."},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072160"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1800451"},{"key":"e_1_3_4_30_1","unstructured":"Abecma (idecabtagene vicleucel) suspension for intravenous infusion. [package insert]. Summit (NJ): Celegene Corporation a Bristol-Myers Squibb Company; 2021."},{"key":"e_1_3_4_31_1","unstructured":"Carvykti (ciltacabtagene autoleucel) suspension for intravenous infusion. [package insert]. Horsham (PA): Janssen Biotech Inc; 2022."},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303379"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213614"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181179"},{"key":"e_1_3_4_35_1","unstructured":"Elrexfio (elranatamab-bcmm) injection for subcutaneous use. [package insert]. New York (NY): Pfizer Inc; 2023."},{"key":"e_1_3_4_36_1","unstructured":"Talvey (talquetamab-tgvs) injection for subcutaneous use. [package insert]. Horsham (PA): Janssen Biotech Inc; 2023."},{"key":"e_1_3_4_37_1","unstructured":"Tecvayli (teclistamab-cqyv) injection for subcutaneous use. [package insert]. Horsham (PA): Janssen Biotech Inc; 2022."},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.8006"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS8064"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000975296.46536.6a"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2583668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:48:05Z","timestamp":1766400485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2583668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2583668"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2583668","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"type":"print","value":"1369-6998"},{"type":"electronic","value":"1941-837X"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}